MedCap AB (publ)
MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout. It prefers to invest in healthcare equipment and services, biotechnology, life sciences, pharmaceuticals, med tech and assistive tech companies. The firm prefers to invest in small to medium… Read more
MedCap AB (publ) (MCAP) - Total Assets
Latest total assets as of December 2025: Skr2.61 Billion SEK
Based on the latest financial reports, MedCap AB (publ) (MCAP) holds total assets worth Skr2.61 Billion SEK as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
MedCap AB (publ) - Total Assets Trend (2007–2025)
This chart illustrates how MedCap AB (publ)’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
MedCap AB (publ) - Asset Composition Analysis
Current Asset Composition (December 2025)
MedCap AB (publ)'s total assets of Skr2.61 Billion consist of 38.0% current assets and 62.0% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr370.40 Million | 14.2% |
| Accounts Receivable | Skr349.60 Million | 13.4% |
| Inventory | Skr271.40 Million | 10.4% |
| Property, Plant & Equipment | Skr379.20 Million | 14.6% |
| Intangible Assets | Skr566.30 Million | 21.7% |
| Goodwill | Skr662.70 Million | 25.4% |
Asset Composition Trend (2007–2025)
This chart illustrates how MedCap AB (publ)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: MedCap AB (publ)'s current assets represent 38.0% of total assets in 2025, an increase from 34.7% in 2007.
- Cash Position: Cash and equivalents constituted 14.2% of total assets in 2025, up from 4.4% in 2007.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 46.0% of total assets, an increase from 14.0% in 2007.
- Asset Diversification: The largest asset category is goodwill at 25.4% of total assets.
MedCap AB (publ) Competitors by Total Assets
Key competitors of MedCap AB (publ) based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
MedCap AB (publ) - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - MedCap AB (publ) generates 0.81x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, MedCap AB (publ) generates $8.43 in net profit.
MedCap AB (publ) - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.01 | 2.77 | 1.69 |
| Quick Ratio | 1.46 | 1.96 | 1.12 |
| Cash Ratio | 0.75 | 1.12 | 0.00 |
| Working Capital | Skr497.10 Million | Skr 586.00 Million | Skr 184.00 Million |
MedCap AB (publ) - Advanced Valuation Insights
This section examines the relationship between MedCap AB (publ)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.86 |
| Latest Market Cap to Assets Ratio | 0.19 |
| Asset Growth Rate (YoY) | 30.9% |
| Total Assets | Skr2.61 Billion |
| Market Capitalization | $507.41 Million USD |
Valuation Analysis
Below Book Valuation: The market values MedCap AB (publ)'s assets below their book value (0.19 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: MedCap AB (publ)'s assets grew by 30.9% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for MedCap AB (publ) (2007–2025)
The table below shows the annual total assets of MedCap AB (publ) from 2007 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Skr2.61 Billion | +30.86% |
| 2024-12-31 | Skr1.99 Billion | +19.81% |
| 2023-12-31 | Skr1.66 Billion | +16.29% |
| 2022-12-31 | Skr1.43 Billion | +22.21% |
| 2021-12-31 | Skr1.17 Billion | +8.16% |
| 2020-12-31 | Skr1.08 Billion | +28.37% |
| 2019-12-31 | Skr842.30 Million | +25.92% |
| 2018-12-31 | Skr668.90 Million | +11.45% |
| 2017-12-31 | Skr600.20 Million | +6.58% |
| 2016-12-31 | Skr563.16 Million | -11.55% |
| 2015-12-31 | Skr636.73 Million | +15.95% |
| 2014-12-31 | Skr549.16 Million | -8.63% |
| 2013-12-31 | Skr601.01 Million | +64.77% |
| 2012-12-31 | Skr364.76 Million | +17.40% |
| 2011-12-31 | Skr310.70 Million | +0.22% |
| 2010-12-31 | Skr310.03 Million | +1.70% |
| 2009-12-31 | Skr304.84 Million | +51.96% |
| 2008-12-31 | Skr200.60 Million | +2.59% |
| 2007-12-31 | Skr195.54 Million | -- |